References
- Judson MA. Extrapulmonary sarcoidosis. Semin Respir Crit Care Med. 2007;28:83–101.
- Gavilán F, Pereda T, Sousa JM, et al. Hepatic cirrhosis with sarcoid granulomas. Differential diagnosis and liver transplantation: a case report. Transplant Proc. 2003;35:713–714.
- Cozier YC, Berman JS, Palmer JR. Sarcoidosis in black women in the United States: data from the Black Women's Health Study. Chest. 2011;139:144–150.
- Saidha S, Sotirchos ES, Eckstein C. Etiology of sarcoidosis: does infection play a role? Yale J Biol Med. 2012;85:133–141.
- Smith G, Brownell I, Sanchez M, et al. Advances in the genetics of sarcoidosis. Clin Genet. 2008;73:401–412.
- Karagiannidis A, Karavalaki M, Koulaouzidis A. Hepatic sarcoidosis. Ann Hepatol. 2006;5:251–256.
- Holmes J, Lazarus A. Sarcoidosis: extrathoracic manifestations. Dis Mon. 2009;55:675–692.
- Irani SK, Dobbins WO. Hepatic granulomas: review of 73 patients from one hospital and survey of the literature. J Clin Gastroenterol. 1979;1:131–143.
- Devaney K, Goodman ZD, Epstein MS, et al. Hepatic sarcoidosis. Clinicopathologic features in 100 patients. Am J Surg Pathol. 1993;17:1272–1280.
- Vatti R, Sharma OP. Course of asymptomatic liver involvement in sarcoidosis: role of therapy in selected cases. Sarcoidosis Vasc Diffuse Lung Dis. 1997;14:73–76.
- Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;22:2153–2165.
- Zissel G, Prasse A, Muller-Quernheim J. Immunologic response of sarcoidosis. Semin Respir Crit Care Med. 2010;31:390–403.
- Schürmann M. Genetics of sarcoidosis. Semin Respir Crit Care Med. 2003;24:213–222.
- Lazarus A. Sarcoidosis: epidemiology, etiology, pathogenesis, and genetics. Dis Mon. 2009;55:649–660.
- Valeyre D, Prasse A, Nunes H, et al. Sarcoidosis. Lancet. 2014;383:1155–1167.
- Newman LS, Rose CS, Bresnitz EA, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med. 2004;170:1324–1330.
- Modaresi Esfeh J, Culver D, Plesec T, et al. Clinical presentation and protocol for management of hepatic sarcoidosis. Expert Rev Gastroenterol Hepatol. 2015;9:349–358.
- Dulai PS, Rothstein RI. Disseminated sarcoidosis presenting as granulomatous gastritis: a clinical review of the gastrointestinal and hepatic manifestations of sarcoidosis. J Clin Gastroenterol. 2012;46:367–374.
- Maddrey WC, Johns CJ, Boitnott JK, et al. Sarcoidosis and chronic hepatic disease: a clinical and pathologic study of 20 patients. Medicine (Baltimore). 1970;49:375–395.
- Cremers J, Drent M, Driessen A, et al. Liver-test abnormalities in sarcoidosis. Eur J Gastroenterol Hepatol. 2012;24:17–24.
- Lebacq EG, Heller F. LP-X test in sarcoidosis patients with liver involvement: comparison with other liver function tests. Ann N Y Acad Sci. 1976;278:439–444.
- Tadros M, Forouhar F, Wu GY. Hepatic sarcoidosis. J Clin Transl Hepatol. 2013;1:87–93.
- Inuzuka S, Ueno T, Tateishi H, et al. A patient with hepatic granuloma formation and angiotensin-converting enzyme production by granuloma cells during clinical relapse of hepatitis A. Pathol Int. 1994;44:391–397.
- Fløe A, Hoffmann HJ, Nissen PH, et al. Genotyping increases the yield of angiotensin-converting enzyme in sarcoidosis-a systematic review. Dan Med J. 2014;61:A4815.
- Lieberman J. Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am J Med. 1975;59:365–372.
- Studdy PR, Bird R. Serum angiotensin converting enzyme in sarcoidosis – its value in present clinical practice. Ann Clin Biochem. 1989;26:13–18.
- Inoue M, Chiba T, Zen Y, et al. Hepatic sarcoidosis with an increased serum level of immunoglobulin G4. Intern Med. 2012;51:3095–3098.
- Rudzki C, Ishak KG, Zimmerman HJ. Chronic intrahepatic cholestasis of sarcoidosis. Am J Med. 1975;59:373–387.
- Thomas E, Micci D. Chronic intrahepatic cholestasis with granulomas and biliary cirrhosis. Enigmatic disease and therapeutic dilemma. JAMA. 1977;238:337–338.
- Bass NM, Burroughs AK, Scheuer PJ, et al. Chronic intrahepatic cholestasis due to sarcoidosis. Gut. 1982;23:417–421.
- Pereira-Lima J, Schaffner F. Chronic cholestasis in hepatic sarcoidosis with clinical features resembling primary biliary cirrhosis. Report of two cases. Am J Med. 1987;83:144–148.
- Farouj NE, Cadranel JF, Mofredj A, et al. Ductopenia related liver sarcoidosis. World J Hepatol. 2011;3:170–174.
- Blich M, Edoute Y. Clinical manifestations of sarcoid liver disease. J Gastroenterol Hepatol. 2004;19:732–737.
- Rubin E, Schaffner F, Popper H. Primary biliary cirrhosis. Chronic non suppurative destructive cholangitis. Am J Pathol. 1965;46:387–407.
- Ebert E. Gastrointestinal and hepatic manifestations of sarcoidosis. Am J Gastroenterol. 2008;103:3184–3192.
- Alam I, Levenson SD, Ferrell LD, et al. Diffuse intrahepatic biliary strictures in sarcoidosis resembling sclerosing cholangitis. Case report and review of the literature. Dig Dis Sci. 1997;42:1295–1301.
- Romero-Gómez M, Suárez-García E, Otero MA, et al. Sarcoidosis sclerosing cholangitis and chronic atrophic autoimmune gastritis: a case of infiltrative sclerosing cholangitis. J Clin Gastroenterol. 1998;27:162–165.
- Ishak KG. Sarcoidosis of the liver and bile ducts. Mayo Clin Proc. 1998;73:467–472.
- Bloom R, Sybert A, Mascatello VJ. Granulomatous biliary tract obstruction due to sarcoidosis. Report of a case and review of the literature. Am Rev Respir Dis. 1978;117:783–787.
- Rezeig MA, Fashir BM. Biliary tract obstruction due to sarcoidosis: a case report. Am J Gastroenterol. 1996;92:527–528.
- Baughman RP. Sarcoidosis usual and unusual manifestations. Chest. 1988;94:165–170.
- Valla D, Pessegueiro-Miranda H, Degott C, et al. Hepatic sarcoidosis with portal hypertension. A report of seven cases with a review of the literature. Q J Med. 1987;63:531–544.
- Moreno-Merlo F, Wanless IR, Shimamatsu K, et al. The role of granulomatous phlebitis and thrombosis in the pathogenesis of cirrhosis and portal hypertension in sarcoidosis. Hepatology. 1997;26:554–560.
- Natalino MR, Goyette RE, Owensby LC, et al. The Budd Chiari syndrome in sarcoidosis. JAMA. 1978;239:2657–2658.
- Russi EW, Bansky G, Pfaltz M, et al. Budd Chiari syndrome in sarcoidosis. Am J Gastroenterol. 1986;81:71–75.
- Aravinthan A, Gelson W, Limbu A, et al. Hepatic sarcoidosis complicating treatment-naive viral hepatitis. World J Hepatol. 2012;4:402–405.
- Moudden MK, Ziadi T, Al Bouzidi A. Sarcoidose in patient with chronic hepatitis C treated with pegylated interferon. Rev Pneumol Clin. 2014;70:362–365.
- Fiel MI, Shukla D, Saraf N, et al. Development of hepatic granulomas in patients receiving pegylated interferon therapy for recurrent hepatitis C virus post liver transplantation. Transpl Infect Dis. 2008;10:184–189.
- Brjalin V, Salupere R, Tefanova V, et al. Sarcoidosis and chronic hepatitis C: a case report. World J Gastroenterol. 2012;18:5816–5820.
- Ozaras R, Tahan V, Mert A, et al. The prevalence of hepatic granulomas in chronic hepatitis C. J Clin Gastroenterol. 2004;38:449–452.
- Snyder N, Martinez JG, Xiao SY. Chronic hepatitis C is a common associated with hepatic granulomas. World J Gastroenterol. 2008;14:6366–6369.
- Fallahi P, Ferri C, Ferrari SM, et al. Cytokines and HCV-related disorders. Clin Dev Immunol. 2012;468107.
- Karaosmanoğlu AD, Onur MR, Saini S, et al. Imaging of hepatobiliary involvement in sarcoidosis. Abdom Imaging. 2015;40:3330–3337.
- Fetzer DT, Rees MA, Dasyam AK, et al. Hepatic sarcoidosis in patients presenting with liver dysfunction: imaging appearance, pathological correlation and disease evolution. Eur Radiol. 2016;16:1–9.
- Kessler A, Mitchell DG, Israel HL, et al. Hepatic and splenic sarcoidosis: ultrasound and MR imaging. Abdom Imaging. 1993;18:159–163.
- Gezer NS, Başara I, Altay C, et al. Abdominal sarcoidosis: cross-sectional imaging findings. Diagn Interv Radiol. 2015;21:111–117.
- Suzuki K, Morise Z, Furuta S, et al. Hepatic sarcoidosis mimicking hilar cholangiocarcinoma: case report and review of the literature. Case Rep Gastroenterol. 2011;5:152–158.
- Cremers JP, Drent M, Baughman RP, et al. Therapeutic approach of hepatic sarcoidosis. Curr Opin Pulm Med. 2012;18:472–482.
- Kennedy PT, Zakaria N, Modawi SB, et al. Natural history of hepatic sarcoidosis and its response to treatment. Eur J Gastroenterol Hepatol. 2006;18:721–726.
- Moller DR. Treatment of sarcoidosis – from a basic science point of view. J Intern Med. 2003;253:31–40.
- Mueller S, Boehme MW, Hofmann WJ, et al. Extrapulmonary sarcoidosis primarily diagnosed in the liver. Scand J Gastroenterol. 2000;35:1003–1008.
- B´echeur H, Dall’osto H, Chatellier G, et al. Effect of ursodeoxycholic acid on chronic intrahepatic cholestasis due to sarcoidosis. Dig Dis Sci. 1997;42:789–791.
- Alenezi B, Lamoureux E, Alpert L, et al. Effect of ursodeoxycholic acid on granulomatous liver disease due to sarcoidosis. Dig Dis Sci. 2005;50:196–200.
- Baratta L, Cascino A, Delfino M, et al. Ursodeoxycholic acid treatment in abdominal sarcoidosis. Dig Dis Sci. 2000;45:1559–1562.
- Lower EE, Baughman RP. The use of low dose methotrexate in refractory sarcoidosis. Am J Med Sci. 1990;299:153–157.
- Baughman RP, Koehler A, Bejarano PA, et al., Role of liver function tests in detecting methotrexate-induced liver damage in sarcoidosis. Arch Intern Med. 2003;163:615–620.
- Malhotra A, Naniwadekar A, Sood G. Hepatobiliary and pancreatic: cirrhosis secondary to hepatic sarcoidosis. J Gastroenterol Hepatol. 2008;23:1942.
- Ulbricht KU, Stoll M, Bierwirth J, et al. Successful tumor necrosis factor alpha blockade treatment in therapy-resistant sarcoidosis. Arthritis Rheum. 2003;48:3542–3543.
- Doty JD, Mazur JE, Judson MA. Treatment of sarcoidosis with infliximab. Chest. 2005;127:1064–1071.
- Saleh S, Ghodsian S, Yakimova V, et al. Effectiveness of infliximab in treating selected patients with sarcoidosis. Respir Med. 2006;100:2053–2059.
- Judson MA, Baughman RP, Costabel U, et al. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J. 2008;31:1189–1196.
- Denys BG, Bogaerts Y, Coenegrachts KL, et al. Steroid-resistant sarcoidosis: is antagonism of TNF-alpha the answer? Clin Sci (Lond). 2007;112:281–289.
- Boots AW, Drent M, de Boer VC, et al. Quercetin reduces markers of oxidative stress and inflammation in sarcoidosis. Clin Nutr. 2011;30:506–512.
- Hughes GS Jr, Kataria YP, O’Brien TF Jr, Sarcoidosis presenting as biliary cirrhosis: treatment with chlorambucil. South Med J. 1983;76:1440–1442.
- Casavilla FA, Gordon R, Wright HI, et al. Clinical course after liver transplantation in patients with sarcoidosis. Ann Intern Med. 1993;118:865–866.
- Das D, Smith A, Warnes TW. Hepatic sarcoidosis and renal carcinoma. J Clin Gastroenterol. 1999;28:61–63.
- Nguyen YT, Dupuy A, Cordoliani F, et al. Treatment of cutaneous sarcoidosis with thalidomide. J Am Acad Dermatol. 2004;50:235–241.
- Lazar CA, Culver DA. Treatment of sarcoidosis. Semin Respir Crit Care Med. 2010;31:501–518.
- Park MK, Fontana Jr, Babaali H, et al. Steroid-sparing effects of pentoxifylline in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2009;26:121–131.
- Vanatta JM, Modanlou KA, Dean AG, et al. Outcomes of orthotopic liver transplantation for hepatic sarcoidosis: an analysis of the United Network for Organ Sharing/Organ Procurement and Transplantation Network data files for a comparative study with cholestatic liver diseases. Liver Transpl. 2011;17:1027–1034.
- Lipson EJ, Fiel MI, Florman SS, et al. Patient and graft outcomes following liver transplantation for sarcoidosis. Clin Transplant. 2005;19:487–491.
- Cengiz C, Rodriguez-Davalos M, deBoccardo G, et al. Recurrent hepatic sarcoidosis postliver transplantation manifesting with severe hypercalcemia: a case report and review of the literature. Liver Transpl. 2005;11:1611–1614.